Market Capitalization & Enterprise Value
Research-grade valuation history for BIOA. Track market capitalization versus enterprise value to see the impact of net debt and share changes. Use the interactive chart to explore different horizons; the table updates accordingly to support auditability and export.
Market Cap & Enterprise Value
Comparison of market capitalization and enterprise value over time
Market Cap
Enterprise Value
Market Cap History
Investor Valuation Insights
As of Mar 31, 2026EV/EBITDA
-22.81x
Negative EV/EBITDA usually means negative EBITDA; compare with revenue and cash flow metrics.
EV vs Market Cap Spread
-183.33M
EV is -38.6% vs equity value
Capital Structure Signal
Net Cash Profile
EV premium trend: -34.5 pp vs earliest data
Additional Multiples
EV/Sales: 182.27x
Net Debt/EBITDA: 10.73x
Share count change in dataset: +5.17%
Interpretation guide: EV/EBITDA compares total firm value (debt + equity - cash) to operating earnings. Lower is usually cheaper, but always benchmark against peers, growth rate, margins, and cyclicality.
Market Cap & Enterprise Value Data
Free users can view the latest 3 records. Upgrade to see full history.
| Date | Market Cap | Enterprise Value | Stock Price | Shares |
|---|---|---|---|---|
| Dec 31, 2025 | 475.39M | 292.06M | $13.23 | 35.93M |
| Dec 31, 2024 | 207.57M | -138.07M | $5.79 | 35.85M |
| Dec 31, 2023 | 626.14M | 657.75M | $18.31 | 34.20M |
Dec 31, 2022 | — | — | — | — |